Efficacy of Ustekinumab in Ulcerative Colitis Sustained Through 92 Weeks
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Ustekinumab Is Effective and Safe for Ulcerative Colitis Through 2 Years of Maintenance Therapy
Aliment. Pharmacol. Ther. 2020 Dec 01;52(11-12)1658-1675, R Panaccione, S Danese, WJ Sandborn, CD O'Brien, Y Zhou, H Zhang, OJ Adedokun, I Tikhonov, S Targan, MT Abreu, T Hisamatsu, EJ Scherl, RW Leong, DS Rowbotham, RP Arasaradnam, BE Sands, C MaranoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.